Frontiers in Diabetes Research: Biological Bases for Complications of Diabetes

Meeting Type Meeting
Start Date 11/17/2018
Start Time 8:00 AM
End Date 11/17/2018
End Time 4:00 PM
Location Center for Continuing Medical Education
Columbia University Vagelos College of Physicians and Surgeons
630 West 168th Street, Unit 39
New York, NY  10032

Phone: (212) 305-3334
Fax: (212) 305-5740
Room(s) No rooms.
Purpose This one-day program at the Naomi Berrie Diabetes Center at Columbia University
is designed for research scientists, clinicians and students with an interest in
the latest insights with regard to the biological basis for medical
complications that affect patients with diabetes, and novel therapeutic
approaches that may mitigate these pathologies.

Specifically, while persistent hyperglycemia may cause microvascular
(retinopathy, nephropathy and neuropathy) disease, knowledge of downstream
molecular effectors is likely to enable more effective therapies to prevent
significant morbidity. Further, a direct link between excess glucose per se and
cardiovascular and liver disease is far less certain, implying that other
comorbid metabolic abnormalities such as hyperinsulinemia/insulin resistance and
dyslipidemia may contribute to these associated disorders.
At the conclusion of this activity, participants will be better able to:

• Recognize the major microvascular and macrovascular complications associated
with diabetes, and associated current treatment paradigms.

• Specify some of the molecular mechanisms linking these complications to

• Discuss novel potential technologies for prevention of diabetes-related
Agenda (pdf) download agenda
Minutes (pdf) None Submitted

No meeting documents found.